Published in Clin Exp Immunol on August 01, 2006
Sarcoidosis vs. Sarcoid-like reactions: The Two Sides of the same Coin? Wien Med Wochenschr (2014) 1.05
Toll like receptors in diseases of the lung. Int Immunopharmacol (2011) 0.97
Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis. Clin Exp Immunol (2007) 0.94
Higher monocyte expression of TLR2 and TLR4, and enhanced pro-inflammatory synergy of TLR2 with NOD2 stimulation in sarcoidosis. J Clin Immunol (2008) 0.92
Study of Toll-like receptor gene loci in sarcoidosis. Clin Exp Immunol (2008) 0.84
Lack of association between toll-like receptor 4 gene polymorphisms and sarcoidosis-related uveitis in Japan. Mol Vis (2009) 0.83
Disordered Toll-like receptor 2 responses in the pathogenesis of pulmonary sarcoidosis. Clin Exp Immunol (2013) 0.82
Toll-like receptor (TLR)-9 genetics and function in sarcoidosis. Clin Exp Immunol (2010) 0.80
Giant cell formation in sarcoidosis: cell fusion or proliferation with non-division? Clin Exp Immunol (2008) 0.80
Toll-like receptor 2 (TLR2) gene polymorphisms are not associated with sarcoidosis in the Japanese population. Mol Vis (2011) 0.79
Association of the TLR4 Asp299Gly polymorphism with lung function in relation to body mass index. BMC Pulm Med (2009) 0.75
CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science (1990) 17.86
Toll-like receptors in innate immunity. Int Immunol (2005) 12.24
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet (2000) 8.79
Problems of reporting genetic associations with complex outcomes. Lancet (2003) 8.11
ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis (1999) 3.69
Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Microbiol (2002) 2.21
Pulmonary sarcoidosis. Allergy (2005) 1.59
High prevalence of Mycobacterium tuberculosis DNA in biopsies from sarcoidosis patients from Catalonia, Spain. Respiration (2005) 1.57
Determination of the TLR4 genotype using allele-specific PCR. Biotechniques (2001) 1.46
Toll-like receptor 4 polymorphisms are associated with resistance to Legionnaires' disease. Proc Natl Acad Sci U S A (2005) 1.39
Serum anti-mycobacterial heat shock proteins antibodies in sarcoidosis and tuberculosis. Tuberculosis (Edinb) (2005) 1.37
Is there a role for microorganisms in the pathogenesis of sarcoidosis? J Intern Med (2003) 1.30
The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease. Inflamm Bowel Dis (2005) 1.26
Mammalian Toll-like receptors: to immunity and beyond. Clin Exp Immunol (2005) 1.23
Mortality of intrathoracic sarcoidosis in referral vs population-based settings: influence of stage, ethnicity, and corticosteroid therapy. Chest (2002) 1.19
Toll-like receptor-4 Asp299Gly polymorphism does not influence progression of atherosclerosis in patients with familial hypercholesterolaemia. Eur J Clin Invest (2004) 1.11
Toll-like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis. Clin Exp Immunol (2006) 1.06
Functional consequences of the Asp299Gly Toll-like receptor-4 polymorphism. Cytokine (2005) 1.01
Association of the ASP299GLY TLR4 polymorphism with COPD. Respir Med (2005) 0.99
TLR4 Asp299Gly and Thr399Ile polymorphisms are very rare in the Chinese population. J Endotoxin Res (2004) 0.99
No evidence for involvement of the Toll-like receptor 4 (TLR4) A896G and CD14-C260T polymorphisms in susceptibility to ankylosing spondylitis. Ann Rheum Dis (2005) 0.96
Toll-like receptor 4 Asp299Gly gene polymorphism and risk of atherothrombosis. Stroke (2004) 0.91
Impact of the Asp299Gly polymorphism in the toll-like receptor 4 (tlr-4) gene on disease course of multiple sclerosis. J Neuroimmunol (2005) 0.91
Lack of association between polymorphisms of the toll-like receptor 4 gene and cerebral ischemia. J Neurol (2004) 0.91
The TLR4 +896 polymorphism is not associated with lipopolysaccharide hypo-responsiveness in leukocytes. Genes Immun (2005) 0.85
Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med (2002) 0.81
Single step high-throughput determination of Toll-like receptor 4 polymorphisms. J Immunol Methods (2004) 0.80
Update in pulmonary carcinoid tumors: a review article. Ann Surg Oncol (2003) 1.82
Statin treatment and reduced risk of pneumonia in patients with diabetes. Thorax (2006) 1.60
Angiotensin-converting enzyme inhibitor use and pneumonia risk in a general population. Eur Respir J (2006) 1.56
Nocardiosis: a case series and a mini review of clinical and microbiological features. Neth J Med (2007) 1.54
Impaired pneumococcal antibody response in bronchiectasis of unknown aetiology. Eur Respir J (2005) 1.48
Lung function in idiopathic pulmonary fibrosis--extended analyses of the IFIGENIA trial. Respir Res (2009) 1.34
Human neutrophils switch to an activated phenotype after homing to the lung irrespective of inflammatory disease. Clin Exp Immunol (2008) 1.30
Systemic cytokine response in patients with community-acquired pneumonia. Eur Respir J (2010) 1.19
Corticosteroid treatment in sarcoidosis. Eur Respir J (2006) 1.13
Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force. Sarcoidosis Vasc Diffuse Lung Dis (2011) 1.07
Inhibitor kappa B-alpha (IkappaB-alpha) promoter polymorphisms in UK and Dutch sarcoidosis. Genes Immun (2003) 1.07
Endpoints for clinical trials of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (2012) 1.07
Atopy and new-onset asthma in young Danish farmers and CD14, TLR2, and TLR4 genetic polymorphisms: a nested case-control study. Clin Exp Allergy (2007) 1.04
Surfactant protein-D predicts survival in patients with idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis (2009) 1.02
Imaging the inflammatory activity of sarcoidosis: sensitivity and inter observer agreement of (67)Ga imaging and (18)F-FDG PET. Q J Nucl Med Mol Imaging (2011) 1.00
Variation in IL7R predisposes to sarcoid inflammation. Genes Immun (2009) 0.98
Acute-phase responsiveness of mannose-binding lectin in community-acquired pneumonia is highly dependent upon MBL2 genotypes. Clin Exp Immunol (2009) 0.97
Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer. Thromb Res (2009) 0.97
Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis. Clin Exp Immunol (2007) 0.94
Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis. Tissue Antigens (2007) 0.93
Genetic variation in the Toll-like receptor gene cluster (TLR10-TLR1-TLR6) influences disease course in sarcoidosis. Tissue Antigens (2012) 0.92
Bronchoalveolar lavage cell pattern from healthy human lung. Clin Exp Immunol (2012) 0.92
Rituximab in life threatening antisynthetase syndrome. Rheumatol Int (2009) 0.90
T-cell activation profiles in different granulomatous interstitial lung diseases--a role for CD8+CD28(null) cells? Clin Exp Immunol (2009) 0.89
Effective Prolonged Therapy with Voriconazole in a Lung Transplant Recipient with Spondylodiscitis Induced by Scedosporium apiospermum. Case Rep Infect Dis (2011) 0.88
Predicting prognosis in idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis (2010) 0.87
18F-FDG PET in sarcoidosis: an observational study in 12 patients treated with infliximab. Sarcoidosis Vasc Diffuse Lung Dis (2008) 0.87
Combined influence of proton-pump inhibitors, calcium-channel blockers and CYP2C19*2 on on-treatment platelet reactivity and on the occurrence of atherothrombotic events after percutaneous coronary intervention. J Thromb Haemost (2011) 0.85
Pattern of diffusion disturbance related to clinical diagnosis: The K(CO) has no diagnostic value next to the DL(CO). Respir Med (2005) 0.84
Nitric oxide diffusing capacity versus spirometry in the early diagnosis of emphysema in smokers. Respir Med (2009) 0.84
Genetic variability in the IL1RN gene and the balance between interleukin (IL)-1 receptor agonist and IL-1β in idiopathic pulmonary fibrosis. Clin Exp Immunol (2011) 0.84
Reduction of variability of exhaled nitric oxide in healthy volunteers. Respir Med (2002) 0.81
Genetic variation in GREM1 is a risk factor for fibrosis in pulmonary sarcoidosis. Tissue Antigens (2011) 0.81
Effect of variation in ITGAE on risk of sarcoidosis, CD103 expression, and chest radiography. Clin Immunol (2009) 0.81
18F-FDG PET as a predictor of pulmonary function in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (2011) 0.81
Response to pneumococcal vaccination in mannose-binding lectin-deficient adults with recurrent respiratory tract infections. Clin Exp Immunol (2014) 0.81
MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases. Clin Exp Immunol (2010) 0.81
The effect of red cell transfusion on nitric oxide diffusing capacity. Respiration (2005) 0.80
Angiotensin II receptor type 1 1166 A/C and angiotensin converting enzyme I/D gene polymorphisms in a Dutch sarcoidosis cohort. Sarcoidosis Vasc Diffuse Lung Dis (2010) 0.80
Toll-like receptor (TLR)-9 genetics and function in sarcoidosis. Clin Exp Immunol (2010) 0.80
Is the different T helper cell activity in sarcoidosis and extrinsic allergic alveolitis also reflected by the cellular bronchoalveolar lavage fluid profile? Sarcoidosis Vasc Diffuse Lung Dis (1997) 0.80
YKL-40 and matrix metalloproteinases as potential biomarkers of inflammation and fibrosis in the development of bronchiolitis obliterans syndrome. Sarcoidosis Vasc Diffuse Lung Dis (2013) 0.80
Serum thymus and activation regulated chemokine levels post-lung transplantation as a predictor for the bronchiolitis obliterans syndrome. Clin Exp Immunol (2008) 0.80
Mannose-binding lectin deficiency linked to cytomegalovirus (CMV) reactivation and survival in lung transplantation. Clin Exp Immunol (2011) 0.79
Alveolar volume determined by single-breath helium dilution correlates with the high-resolution computed tomography-derived nonemphysematous lung volume. Respiration (2005) 0.79
The influence of variation in the P2Y12 receptor gene on in vitro platelet inhibition with the direct P2Y12 antagonist cangrelor. Thromb Haemost (2009) 0.79
Chlamydia psittaci: a relevant cause of community-acquired pneumonia in two Dutch hospitals. Neth J Med (2016) 0.79
Single nucleotide polymorphisms in inflammation-related genes are associated with venous thromboembolism. Eur J Intern Med (2010) 0.78
CA 15-3 as an alternative marker for KL-6 in fibrotic lung diseases. Sarcoidosis Vasc Diffuse Lung Dis (2010) 0.77
Lung transplantation affects expression of the chemokine receptor type 4 on specific T cell subsets. Clin Exp Immunol (2011) 0.77
Complement receptor 1 single nucleotide polymorphisms in Czech and Dutch patients with sarcoidosis. Tissue Antigens (2007) 0.77
Influence of repeated maximal exercise testing on biomarkers and fatigue in sarcoidosis. Brain Behav Immun (2013) 0.77
No association between interleukin-18 gene polymorphisms and haplotypes in Dutch sarcoidosis patients. Tissue Antigens (2004) 0.76
Therapy in pneumonia: what is beyond antibiotics? Neth J Med (2011) 0.76
Genetics of sarcoidosis: role of co-stimulatory genes? Respiration (2005) 0.75